Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk identification to improve prevention and management strategies. Traditional risk ...
BOSTON--(BUSINESS WIRE)--Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced its participation in AF Symposium 2026, taking place February 5–8 in Boston, ...
Visit Vektor Medical at Booth 208 to Learn More about vMap®, the VITAL-EP Registry’s AF Findings, and the Newly Released Atrial Flutter Workflow At this year’s meeting, a featured study titled "High ...
Vektor Medical to Showcase VITAL-EP Registry’s Atrial Fibrillation Results, Including Fast, Zero-Fluoro PVI+ Ablation Workflow, and New Atrial Flutter Capabilities Visit Vektor Medical at Booth 208 to ...
Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced its participation in AF Symposium 2026, taking place February 5–8 in Boston, where new clinical data ...
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. If you are wondering whether ...
It is first thing in the morning and nurses are waiting to take Michael Robinson to theatre. He has been living with atrial fibrillation (AF), a common heart rhythm problem, affecting 1.4m people in ...
Daniel Moore was about 30 the first time it happened. At the end of a long, hot, stressful day, he chugged an ice-cold glass of milk. "It felt like a bunny rabbit trying to jump out of my chest," said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results